scholarly journals TCT-465 Anticoagulation Practices Using ACT in Patients With Respiratory Failure on Venovenous ECMO: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 78 (19) ◽  
pp. B191
Author(s):  
Kanak Parmar ◽  
Wasawat Vutthikraivit ◽  
Amritpal Singh ◽  
Ana Morataya ◽  
Gaspar Del Rio-Pertuz ◽  
...  
2019 ◽  
Author(s):  
Jing Xiong ◽  
Li Zhang ◽  
Lei Bao

Abstract Background: Extracorporeal membrane oxygenation (ECMO) has been increasingly used for severe neonatal respiratory failure refractory to conventional treatments. To systematically evaluate the complications and mortality of venovenous ECMO in the treatment of neonatal respiratory failure, we performed a systematic review and meta-analysis of all the related studies. Methods: PubMed, Embase, and Cochrane Library were searched. The retrieval period was from the establishment of the database to February 2019. Two investigators independently screened articles according to the inclusion and exclusion criteria. The quality of article was assessed by the Newcastle-Ottawa scale (NOS). The meta-analysis was performed by Stata 15.0 software. Results: Four observational studies were included, with a total of 347 newborns. The overall mortality at hospital charge was 12% (5% - 18%) with a heterogeneity of I2 = 73.8% (p = 0.01). Two studies reported mortality during ECMO and after decannulation, with 10% (0.8% -19.2%) and 6.1% (2.6% - 9.6%) respectively. The most common complications associated with venovenous ECMO were: pneumothorax (20.6%), hypertension (20.4%), cannula dysfunction (20.2%), seizure (14.9%), renal failure requiring hemofiltration (14.7%), infectious complications (10.3%), thrombi (7.4%), intracranial hemorrhage or infarction (6.6%), hemolysis (5.3%), cannula site bleeding (4.4%), gastrointestinal bleeding (3.7%), oxygenator failure (2.8%), other bleeding events (2.8%), brain death (1.9%), and myocardial stun (0.9%). Conclusion: The overall mortality at discharge of venovenous ECMO in the treatment of neonatal respiratory failure was 12%. Although complications are frequent, the survival rate during hospitalization is still high. Further larger samples and higher quality of randomized controlled trials (RCT) are needed to clarify the efficacy and safety of this technique in the treatment of neonatal respiratory failure.


2019 ◽  
Vol 50 ◽  
pp. 310
Author(s):  
Paula G. David-João ◽  
Murilo H. Guedes ◽  
Alvaro Réa-Neto ◽  
Viviane B. de Oliveira Chaiben ◽  
Cristina P. Baena

2019 ◽  
Vol 49 ◽  
pp. 84-91 ◽  
Author(s):  
Paula G. David-João ◽  
Murilo H. Guedes ◽  
Álvaro Réa-Neto ◽  
Viviane B. de Oliveira Chaiben ◽  
Cristina P. Baena

2019 ◽  
Vol 46 (1) ◽  
pp. 36-45 ◽  
Author(s):  
Michael E. Wilson ◽  
Aniket Mittal ◽  
Bibek Karki ◽  
Claudia C. Dobler ◽  
Abdul Wahab ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document